PATENT PORTFOLIO 2013

Similar documents
STEM CELL FELLOWSHIP

FACULTY OF ALLIED HEALTH SCIENCES

A LIFE THAT IS BORN MAKES LIFE GROW. CORD BLOOD: CURRENT EXPERIENCES AND FUTURE PROGRAMMES

A LIFE THAT IS BORN MAKES LIFE GROW. CORD BLOOD: CURRENT EXPERIENCES AND FUTURE PROGRAMMES

Wilson Disease Research and Care. Looking Forward Ann Arbor, Michigan September 6, 2014 Fred Askari MD, PhD

San Diego Stem Cell Treatment Center Frequently Asked Questions

A Genetic Analysis of Rheumatoid Arthritis

Project ideas of University of Udine for Horizon 2020 Health 2014/2015

your complete stem cell bank

Chapter 16 Reproductive Technology, Gene Therapy, and Stem Cells (modified)

Jornada Informativa en Bioeconomía. Retos Colaboración 2016

Stem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst.

INNOVATION IN CNS DRUG DISCOVERY: FROM SMALL MOLECULES TO BIOLOGIC THERAPIES

Roche Position on Human Stem Cells

How To Become A Physio And Rehabilitation Medicine Specialist

Cord Blood, Cord Life

HUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE

Positions Available in SINAPSE INSTITUTE in Singapore

Gene Therapy and Genetic Counseling. Chapter 20

PARKINSON S DISEASE MULTIPLE DOMAINS

CCR Biology - Chapter 9 Practice Test - Summer 2012

Version Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Reproductive System & Development: Practice Questions #1

15 Stem Cell Research

BIOPATENTS IN CHINA. Christopher Shaowei Heather Lin. April 4, 2014, Budapest, Hungary 2014/4/4 NTD IP ATTORNEYS

RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE. Graduatoria e Finanziamento

Concepts of Normality and Abnormality

4.11 Healthcare Technology Co-operatives Version 4 (July 2015)

Non-invasive prenatal detection of chromosome aneuploidies using next generation sequencing: First steps towards clinical application

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

The Nuts and Bolts of Multiple Sclerosis. Rebecca Milholland, M.D., Ph.D. Center for Neurosciences

House Resolution No. 37

FGF-1 as Cosmetic Supplement

How To Find Out If The Gulf War And Health Effects Of Serving In The Gulf Wars Are Linked To Health Outcomes

Stem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine

Career Opportunities within the French Alliance for Life and Health Sciences

Gene mutation and molecular medicine Chapter 15

Summary Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in People with Multiple Sclerosis (MS)

Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH

What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives

Stem Cell Research: Adult or Somatic Stem Cells

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

3D Cell Culture mimsys G

Intended Use: The kit is designed to detect the 5 different mutations found in Asian population using seven different primers.

The NeurOmics team at a recent project meeting

Genetic Mutations Cause Many Birth Defects:

FACULTY OF MEDICAL SCIENCE

Corporate Medical Policy Genetic Testing for Fanconi Anemia

Patent issues in Industrial Biotech:

Should Stem Cells Be Used To Treat Human Diseases?

Neural Tube Defects - NTDs

Stem cells will change medicine as we know it. Are you ready? STEM CELL BANKING

Innovation Platform: Sudden Cardiac Death

The Brain and Spine CenTer

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA

By Dr. Mindy Aisen CEO and Director United Cerebral Palsy Research and Educational Foundation CEREBRAL PALSY RESEARCH

Information for patients and the public and patient information about DNA / Biobanking across Europe

Preimplantation Genetic Diagnosis. Evaluation for single gene disorders

The following chapter is called "Preimplantation Genetic Diagnosis (PGD)".

Personalized medicine in China s healthcare system

Cochlear Hyperacusis and Vestibular Hyperacusis

F r e q u e n t l y A s k e d Q u e s t i o n s

Advances in Biology and Treatment of Malignant Brain Gliomas

Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae

It s not something you want to think about, but it s something you want to prepare for.

Lecture 13: DNA Technology. DNA Sequencing. DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology

OpenMedicine Foundation (OMF)

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

Griffith University - Case for Support. Mesothelioma Research Program

Single-Cell Whole Genome Sequencing on the C1 System: a Performance Evaluation

Stem Cells. Part 1: What is a Stem Cell?

5 Frequently Asked Questions About Adult Stem Cell Research

Sarah Chandler A/Head, Regulatory and Scientific Section Medical Devices Bureau

Materials and Methods. Blocking of Globin Reverse Transcription to Enhance Human Whole Blood Gene Expression Profiling

HISTO TYPE SSP Immunogenetic Diagnostics. Robust and fast - validated Taq Polymerase included

[Indian Stem Cell Banking Market: Trends & Opportunities ( )]

Dr Alexander Henzing

Alberta/Novartis Translational Research Fund Opportunity. Program Guide 2014/2015

Optional Tests Offered Before and During Pregnancy

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

Course Descriptions. I. Professional Courses: MSEG 7216: Introduction to Infectious Diseases (Medical Students)

MDM. Metabolic Drift Mutations - Attenuation Technology

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

CompleteⅡ 1st strand cdna Synthesis Kit

AUTOHEPARIN (ERC-2008-AdG) Automated Synthesis of Heparin and Chondroitin Libraries for the Preparation of Diverse Carbohydrate Arrays

Leukemia Drug Pathway Analyzer

Carrier detection tests and prenatal diagnosis

Clinical and Therapeutic Cannabis Information. Written by Cannabis Training University (CTU) All rights reserved

STROKE CARE NOW NETWORK CONFERENCE MAY 22, 2014

REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Class Time: 30 minutes. Other activities in the Stem Cells in the Spotlight module can be found at:

Documentation Requirements ADHD

HyStem. Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH. esibio.com

Human stem cell research: a novel technology that will benefit patients Information and Position Paper

AHCF Family Meeting. Raleigh N.C., July The Italian Association A.I.S.EA: Activity report (1) Social Activities. A.I.S.

Corporate Medical Policy

Collaborative Network Award Planning Grants Project Summaries

Transcription:

PATENT PORTFOLIO 2013

n Title Inventors Applicants Status Field of use Description Suggested Applications 01 04 Probes for the genomic typing of erytrocyte system, oligonucleotide methods and relative diagnostic kit Apparatus for treating neurological disorders by brain stimulation Poli Francesca Crespiatico Loretta Drago Francesca Espandas De Aras Alejandro Villa Maria Antonietta Priori Alberto Foffani Guglielmo Rossi Lorenzo 50% UNIMI 50% application (CA) (IT, EP, US, IL) 25.01.2005 application (CA) (IT, EP, US, IL) 28.10.2005 The present invention provides methods for the oligonucleotide specific probes for genomic typing of erytrocyte system and relative diagnostic kit. This method can be used for medical-biotechnology. The invention relates to an innovative system for Deep Brain Stimulation (DBS, which is able to correlate the typical EEG of certain neurodegenerative diseases with the therapeutic stimulation delivered at the nervous tissues. In this way the stimulation will be always regulated according to the patient need. The advantage related to the use of molecular techniques is economic and fast genomic typing of samples blood. The therapy is optimized and specifically adapted to each patient. The system installation procedure is safe, poorly invasive and it can be carried out under local anesthesia in the case of Parkinson s desease. 09 Process for reducing neuromuscolar fatigue caused by exercise Priori Alberto Cogia Manian Filippo Marceglia Sara (EP) 21.06.2007 The present invention is relates to a process for reducing neuromuscolar fatigue caused by exercise, in particular in a rehabilitation exercises and secondary syndromes of tireless To provide an alternative process for reducing neuromuscolar fatigue, in a healty person submit at phisical exercise. 11 Method for the genomic typing of erythrocyte systems, oligonucleotide probes and relative diagnostic kits. Poli Francesca Drago Francesca Karpasitou Katerina application (US, CA, IL) (IT, EP) The present invention relates to a method for the genomic typing of erythrocyte system, oligonucleotide probes and relative diagnostic kits. The advantage related to the use of molecular techniques is economic and fast genomic typing of samples blood 13.03.2007

n Title Inventors Applicants Status Field of use 12 Method of stem cells expansion ex-vivo 13 Kit for voice audiometry with praxis control " 14 15 Innovative method of Porphyria diagnosis Piastrinic fraction deriving from placentar blood Lazzari Lorenza Montemurro Tiziana Giordano Rosaria Rebulla Paolo Sirchia Girolamo Cesarani Antonio Di Bernardino Federica Di Pierro Elena Cappellini Maria Besana Valeria Brancaleoni Valentina Rebulla Paolo Lazzari Lorena Parazzi Valentina Greppi Noemi 50% UNIMI 50% application (US, IL) (IT, MX) 13.03.2007 22.05.2007 (IT, EP) 30.06.2008 application (EP) (IT, US) 18.07.2008 Clinic Description The present invention relates to a colture inclusive of growth means and a combination of cytokines for expanding ex-vivo stem cells or progenic cells and cells differentiated, and use of this cells. The present invention relates to a kit for audiometry, in particular for voice audiometry with movement coordination control. The invention applies to the analysis and study in depth of the degree of hearing disturbance in a subject with suspected reduction in the auditory sensitivity (hipacusia) Porphyrias are a group of heterogeneous disorders caused by genetic defects of enzymes involved in heme biosynthetic pathway The present invention offers seven panels of probes able to recognize the seven genes of heme pathway involved in porphyrias and their surrounding regions. The present invention relates to a piastrinic fractions deriving from placentar blood with high concentration of piastrinic factors and gel. Moreover the invention relates methods to prepare this piastrinic fraction from placentar blood and they applications. Suggested Applications To provide an easy, standardized and reproducible ex vivo expansion system based on a proper mixture of cytokines in a animal-free medium that defines optimal culture conditions able either to expand and maintain stem cells and to amplify progenitor cells from different cell sources. This protocol has been already successfully tested in a clinical setting. To provide a kit for audiometry that is also able to evaluate the semantic-oral comprehension of a subject affected by hypocusia thought the Porphyria is often misdiagnosed because the symptoms are common with several other disorders. So far only point mutations or small deletions-insertions in the coding regions of heme genes have been described. The use of these probes will allow a fast and simple diagnosis, detecting deletion or duplication of genes involved in the pathway. Furthermore, this method is easier to use, faster and cheaper than other methods. To provide a medicament made of a piastrinic fraction to treat damaged tissues and other application.

n Title Inventors Applicants Status Field of use 16 New melanocortins with antimicrobial activity Catania Anna Bonino Ferruccio Grieco Paolo Novellino Ettore application (CA, IL, IN, JP) (EP, US) Description The present invention finds application in the therapeutic fields. In particular, it concerns new syntetic melanocortin peptides having improved antimicrobial activity. Suggested Applications Compound with major anti-inflammatory, anti-infective and antimicrobial activity for therapeutic use, especially against Candida albicans and Staphilococcus aureus. 17/18 Tecnosalute Bonino Ferruccio 19.01.2009 Italian trademark 18.03.2009 Education Figurative for educational and medical services. A new approach of multidisciplinary educational courses. 19 Method of threedimensional co-culture of podocytes and endothelial cells and in-vitro co-culture system thereof Rastaldi Maria Pia Li Min application (EP, US, IL) 17.12.2009 20 Method for dental pulp cryopreservation Gioventù Silvia, Frasca Stefania, Rebulla Paolo, Bonino Ferruccio, Lazzari Lorenza, Montelattici Tiziana, Andriolo Gabriella application (EP, US, IL) 12.05.2010 21 Center for the Prevention and Diagnosis of Celiac Disease 22 Method for determining inhomogeneity in animal Tissue and Equipment to Elli Luca Gattinoni Luciano Cadringer Paolo CressoniMassimo Italian trademark 01.06.2011 Education Figurative for

implement it 13.12.2011 23 Collecting Device for Analysis of biological Material 24 Method and diagnostic Kit to detect Gluten Sensitivity Messa Pier Giorgio Spinardi Laura Provasi Stefano Elli Luca Bardella Maria Teresa Tomba Carolina Roncoroni Leda 50% Tecnoline 50% 04.04.2012 Data deposito: 15.11.2012 Clinica/Diagno stica Method for determining whether a subject is sensitive to gluten and a kit for carrying out said method. 25 Method of noninvasive prenatal diagnosis Debora Lattuada application Data deposito: 23.04.2013 Clinica/Diagno stica Method for the isolation of intact fetal erythroblasts from a sample of peripheral blood of a pregnant woman and diagnostic kit thereof.